Epigenetic derepression converts PPAR gamma into a druggable target in triple-negative and endocrine-resistant breast cancers

• Main Authors: Loo, Ser Yue, Syn, Nicholas L, Koh, Angele Pei-Fern, Teng, Janet Cheng-Fei, Deivasigamani, Amudha, Tan, Tuan Zea, Thike, Aye Aye, Vali, Shireen, Kapoor, Shweta, Wang, Xiaoyuan, Wang, Jiong Wei, Tan, Puay Hoon, Yip, George W, Sethi, Gautam, Huang, Ruby Yun-Ju, Hui, Kam Man, Wang, Lingzhi, Goh, Boon Cher, Kumar, Alan Prem
• Other Authors: CANCER SCIENCE INSTITUTE OF SINGAPORE
• Format: Article
• Language: English
• Published: SPRINGERNATURE 2021
• Subjects: Science & Technology; Life Sciences & Biomedicine; Cell Biology; MANGANESE SUPEROXIDE-DISMUTASE; LIGAND TROGLITAZONE; MULTIPLE-MYELOMA; COLON-CANCER; PHASE-II; IN-VITRO; THERAPY; RECEPTOR; EXPRESSION; CARCINOMA
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/208376
• Institution: National University of Singapore

10.1038/s41420-021-00635-5